Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | PLX-4720 | 0.031623 | uM | 3 | 156.25 | 49.48 | 103.33 | 104.50 | 0.9831 | 0.9531 |
| BT-20 | PLX-4720 | 0.1 | uM | 3 | 156.25 | 49.48 | 103.33 | 104.50 | 0.9856 | 0.9645 |
| BT-20 | PLX-4720 | 0.31623 | uM | 3 | 156.25 | 49.48 | 107.33 | 104.50 | 1.0214 | 1.0211 |
| BT-20 | PLX-4720 | 1 | uM | 3 | 156.25 | 49.48 | 135.00 | 104.50 | 1.2868 | 1.5133 |
| BT-20 | PLX-4720 | 3.1623 | uM | 3 | 156.25 | 49.48 | 132.33 | 104.50 | 1.2601 | 1.4595 |
| BT-20 | PLX-4720 | 10 | uM | 3 | 156.25 | 49.48 | 124.67 | 104.50 | 1.1987 | 1.3789 |
| BT-20 | PLX-4720 | 19.9526 | uM | 3 | 156.25 | 49.48 | 71.67 | 104.50 | 0.6867 | 0.4111 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 3 | 156.25 | 49.48 | 125.00 | 104.50 | 1.1952 | 1.3556 |
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 3 | 156.25 | 49.48 | 123.67 | 104.50 | 1.1836 | 1.3391 |
| BT-20 | NVP-TAE684 | 0.01 | uM | 3 | 156.25 | 49.48 | 140.00 | 104.50 | 1.3453 | 1.6499 |
| BT-20 | NVP-TAE684 | 0.031623 | uM | 3 | 156.25 | 49.48 | 108.67 | 104.50 | 1.0438 | 1.0896 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 3 | 156.25 | 49.48 | 140.00 | 104.50 | 1.3354 | 1.6007 |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 3 | 156.25 | 49.48 | 103.33 | 104.50 | 0.9862 | 0.9676 |
| BT-20 | NVP-TAE684 | 1 | uM | 3 | 156.25 | 49.48 | 97.33 | 104.50 | 0.9258 | 0.8470 |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 3 | 156.25 | 49.48 | 66.00 | 104.50 | 0.6341 | 0.3125 |
| BT-20 | NVP-TAE684 | 10 | uM | 3 | 156.25 | 49.48 | 38.67 | 104.50 | 0.3686 | -0.2096 |
| BT-20 | Palbociclib | 0.0033113 | uM | 3 | 156.25 | 49.48 | 93.33 | 96.33 | 0.9805 | 0.9972 |
| BT-20 | Palbociclib | 0.01 | uM | 3 | 156.25 | 49.48 | 96.67 | 96.33 | 1.0104 | 1.0364 |
| BT-20 | Palbociclib | 0.031623 | uM | 3 | 156.25 | 49.48 | 96.33 | 96.33 | 0.9954 | 0.9824 |
| BT-20 | Palbociclib | 0.1 | uM | 3 | 156.25 | 49.48 | 99.67 | 96.33 | 1.0470 | 1.1358 |
| BT-20 | Palbociclib | 0.31623 | uM | 3 | 156.25 | 49.48 | 85.33 | 96.33 | 0.8884 | 0.7676 |
| BT-20 | Palbociclib | 1 | uM | 3 | 156.25 | 49.48 | 86.00 | 96.33 | 0.9091 | 0.8417 |
| BT-20 | Palbociclib | 3.1623 | uM | 3 | 156.25 | 49.48 | 91.00 | 96.33 | 0.9554 | 0.9459 |
| BT-20 | Palbociclib | 10 | uM | 3 | 156.25 | 49.48 | 80.00 | 96.33 | 0.8229 | 0.6039 |
| BT-20 | Palbociclib | 19.9526 | uM | 3 | 156.25 | 49.48 | 56.67 | 96.33 | 0.5812 | 0.1132 |